Picture of Larimar Therapeutics logo

LRMR — Larimar Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Brief: Larimar Therapeutics Q3 Net Income USD -15.499 Million

Oct 30 (Reuters) - Larimar Therapeutics Q3 income from operations USD -18.264
million.
* Q3 operating expenses USD 18.264 million
* Q3 basic EPS USD -0.24

Recent news on Larimar Therapeutics

See all news